Vir Biotechnology to Present at the 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Vir Biotechnology announced that CEO George Scangos, Ph.D., will engage in a virtual fireside chat at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 8:45 am PT / 11:45 am ET. The session will be accessible via live webcast in the Investors section of the Vir website, with an archived version available for 30 days post-event. Vir Biotechnology focuses on treating serious infectious diseases using advanced immunologic technologies, with ongoing projects targeting COVID-19, hepatitis B, influenza A, and HIV.

SAN FRANCISCO, April 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., chief executive officer, will participate in a virtual fireside chat at the 20^th Annual Needham Virtual Healthcare Conference on Tuesday, April 13^th at 8:45 am PT / 11:45 am ET.

A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days.

About Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. For more information, please visit www.vir.bio.

FAQ

When is Vir Biotechnology's virtual fireside chat at the Needham Virtual Healthcare Conference?

Vir Biotechnology's virtual fireside chat is scheduled for April 13, 2021, at 8:45 am PT / 11:45 am ET.

How can I access the live webcast of Vir Biotechnology's presentation?

The live webcast of Vir Biotechnology's presentation can be accessed under the Events & Presentations section on their website at www.vir.bio.

What topics will Vir Biotechnology cover in the upcoming conference?

Vir Biotechnology will discuss its advancements in treating serious infectious diseases, including updates on COVID-19, hepatitis B, influenza A, and HIV.

Will the presentation from Vir Biotechnology be available after the event?

Yes, the presentation will be archived on Vir Biotechnology's website for 30 days following the event.

Who is representing Vir Biotechnology at the Needham Virtual Healthcare Conference?

George Scangos, Ph.D., the CEO of Vir Biotechnology, will represent the company at the conference.